Safest Antidepressant In Pregnancy

Depression is a prevalent mood disorder that affects millions of people worldwide, including pregnant women. Depression during pregnancy can lead to a range of health problems for both the mother and the unborn baby. Therefore, it is essential to seek treatment if you are experiencing depression symptoms while pregnant.

Antidepressants are the most effective treatment approach for depression. However, the question of which antidepressants are safe to use during pregnancy is a common concern among women. Generally speaking, no medication is entirely risk-free during pregnancy, but some antidepressants are safer than others.

Antidepressants Classes

Antidepressants are classified according to their mode of action, and they include:

  • Selective serotonin reuptake inhibitors (SSRIs)
  • Serotonin-norepinephrine reuptake inhibitors (SNRIs)
  • Tricyclic antidepressants (TCAs)
  • Monoamine oxidase inhibitors (MAOIs)
  • Atypical antidepressants

SSRIs are the most commonly prescribed antidepressants during pregnancy because they have a better safety profile than other antidepressant classes. According to studies, SSRIs are not associated with an increased risk of birth defects.

The Safest Antidepressant In Pregnancy

Researchers suggest that Sertraline, a common SSRI, is the safest antidepressant to use during pregnancy. It is associated with a low risk of birth defects, and it does not cross the placenta easily. Therefore, it has minimal effects on the developing fetus. Studies also suggest that sertraline is safe for use during breastfeeding.

Another SSRI, Fluoxetine, is safe to use during pregnancy but in limited doses. Fluoxetine is associated with a slightly increased risk of heart defects when taken during the first trimester. However, studies suggest that the risk is relatively low, and the benefits of the medication outweigh the risks when it comes to treating depression during pregnancy. Fluoxetine is also safe to use during breastfeeding.

Other SSRIs, including citalopram and escitalopram, have limited evidence of causing birth defects. However, they should be used with caution during pregnancy, and their benefits should outweigh the potential risks.

Risks Associated With Antidepressants In Pregnancy

Although the risk of birth defects associated with SSRIs is low, there are still some other potential risks associated with these medications during pregnancy. They include:

  • Premature birth
  • Low birth weight
  • Respiratory distress syndrome in the newborn
  • Bleeding disorders in the newborn
  • Neonatal adaptation syndrome

The risks associated with antidepressants during pregnancy should be carefully considered and weighed against the risks of not treating depression. Untreated depression during pregnancy can lead to serious complications, including:

  • Preeclampsia
  • Preterm labor
  • Low birth weight
  • Postpartum depression
  • Increased risk of suicidal thoughts or actions

Alternative Treatment Approaches For Depression During Pregnancy

While antidepressants are the most effective treatment approach for depression, there are alternative treatment options that can be considered during pregnancy. These alternative approaches include:

  • Psychotherapy: also known as talk therapy, psychotherapy can help treat depression symptoms without the use of medication. It involves talking to a mental health professional, who can provide supportive and helpful feedback to help manage depression symptoms.
  • Exercise: regular exercise has been proven to be beneficial for treating depression. It can help reduce stress levels and release endorphins, which are mood-boosting hormones.
  • Supplements: Omega-3 fatty acid supplements have been found to be helpful in treating depression symptoms. However, it is essential to discuss the use of any supplements with a doctor, as some supplements may interact with prescription medications.

The Bottom Line

Depression is a common concern for pregnant women, and it is essential to seek treatment if you are experiencing depression symptoms. Antidepressants are the most effective treatment approach for depression, and SSRIs are generally considered to be the safest antidepressant class for use during pregnancy. Sertraline is considered to be the safest antidepressant to use during pregnancy, while Fluoxetine can also be used with caution in limited doses. It is essential to discuss any medication use during pregnancy with a doctor, as they can help weigh the benefits and risks to determine the best course of action.


What are the concerns about taking antidepressants during pregnancy?

Antidepressants have been associated with an increased risk of birth defects, particularly when taken during the first trimester. Additionally, some studies have linked antidepressant use during pregnancy to an increased risk of preterm labor, low birth weight, and developmental delays in children. It is essential to weigh the potential risks against the benefits of taking antidepressants during pregnancy.

Which antidepressants are considered the safest during pregnancy?

Selective serotonin reuptake inhibitors (SSRIs) are generally considered the safest antidepressants during pregnancy. This class of drugs includes fluoxetine (Prozac), sertraline (Zoloft), and citalopram (Celexa). However, every pregnant woman’s situation is unique, and treatment options should be decided on a case-by-case basis with a healthcare professional.

What are the alternatives to taking antidepressants during pregnancy?

For women with mild to moderate depression, non-pharmacological treatments such as counseling, exercise, and mindfulness-based therapies may be helpful. In some cases, medication may be necessary, and healthcare professionals may recommend other medications or therapies. Women who are pregnant or planning to become pregnant should always discuss their options with their healthcare provider to ensure the best possible outcomes for themselves and their babies.


1. Fava, G. A., & Offidani, E. (2017). The mechanisms of tolerance in antidepressant action. Progress in Neuro-Psychopharmacology and Biological Psychiatry, 75, 161-167. doi: 10.1016/j.pnpbp.2016.06.006
2. Cohen, L. S., Altshuler, L. L., Harlow, B. L., Nonacs, R. M., Newport, D. J., Viguera, A. C., … & Stowe, Z. N. (2006). Relapse of major depression during pregnancy in women who maintain or discontinue antidepressant treatment. JAMA, 295(5), 499-507. doi: 10.1001/jama.295.5.499
3. Yonkers, K. A., Wisner, K. L., Stewart, D. E., Oberlander, T. F., Dell, D. L., Stotland, N., … Forray, A. (2019). The management of depression during pregnancy: a report from the American Psychiatric Association and the American College of Obstetricians and Gynecologists. Obstetrics & Gynecology, 133(1), e24–e43. doi: 10.1097/AOG.0000000000003017